Buscar
Mostrando ítems 21-30 de 4680
Proportion of patients with heart failure in a specialized clinic eligible for novel therapies Pacientes elegibles para las nuevas terapias de la insuficiencia cardíaca en un policlínico especializado
(Sociedad Medica de Santiago, 2019)
© 2019, Sociedad Medica de Santiago. All rights reserved.Background: Pharmacological treatment improves survival in patients with heart failure with reduced ejection fraction. The use of sacubutril/valsartan and ivabradine ...
Heart failure in chile: patient profile evolution in 11 years of the chilean registry of heart failure (icaro)
(SAGE PUBLICATIONS LTD, 2014)
Infarto do miocárdio experimental em ratos: Análise do modelo
(2009-10-01)
One of the most often used strategies to study the physiopathological alterations caused by coronary occlusion is the use of the experimental infarction model in rats. Among other factors, this is due to the similarities ...
Infarto do miocárdio experimental em ratos: Análise do modelo
(2009-10-01)
One of the most often used strategies to study the physiopathological alterations caused by coronary occlusion is the use of the experimental infarction model in rats. Among other factors, this is due to the similarities ...
The Carvedilol`s Beta-Blockade in Heart Failure and Exercise Training`s Sympathetic Blockade in Healthy Athletes during the Rest and Peak Effort
(WILEY-BLACKWELL, 2010)
In recent years, beta-blocker therapy has become a primary pharmacologic intervention in patients with heart failure by blocking the sympathetic activity. To compare the exercise training`s sympathetic blockade in healthy ...
Association of HDL cholesterol and triglycerides with mortality in patients with heart failure
(Associação Brasileira de Divulgação Científica, 2009)
It has been demonstrated that there is an association between serum lipoproteins and survival rate in patients with ischemic cardiomyopathy, as well as in patients with non-ischemic causes of heart failure. We tested the ...
Oral vasodilators in the treatment of congestive heart failure Vasodilatadores orales en la insuficiencia cardíaca
(1996)
Oral vasodilators have proved to be valuable drugs in the management of systolic or diastolic congestive heart failure. They produce a clinical and hemodynamic relief of preload, afterload or both during the resting state ...